The recent challenges in global chains have highlighted the value of securing critical medications like Ivermectin. Relying on overseas manufacturers exposes countries to significant vulnerabilities, including transportation delays, cost fluctuations, and even geopolitical threats. Moving towards domestic production of Ivermectin offers a multitude… Read More